Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Alexandru Gottlieb, MD, has served Cleveland Clinic in multiple roles since joining the Foundation in 1979. Currently, he holds joint appointments. He is Chairman of the Clinical Council, as well as on the Vascular Anesthesia Staff in the Department of General Anesthesia. Dr. Gottlieb is also the Anesthesiology Institute's liaison to the International Center, as well as an Assistant Professor of Anesthesiology with the Cleveland Clinic Health Science Center of Ohio State University in Cleveland, Ohio.
His interests include vascular anesthesia, anesthesia for bariatric surgery, as well as research and teaching clinical anesthesia. Dr. Gottlieb has lectured, conducted a number of studies and published many articles, book chapters and abstracts on vascular anesthesiology.
Dr. Gottlieb earned his medical degree from the Israel Institute of Technology School of Medicine. He completed his internship at Rambam University Hospital. He also completed two residencies, one with Kaplan Hospital Rehovot Affiliate of Hadassah Medical School in Jerusalem, Israel, and the other at University Hospitals in Cleveland, Ohio.
He is certified by the Israel Board of Anesthesiology and the American Board of Anesthesiology. He was a 1982 Fellow for the American College of Anesthesiologists.
He is a member of numerous medical societies, including the American Medical Association, the American Society of Anesthesiologists, the Society of Critical Care Medicine and the Society of Cardiovascular Anesthesiologists, among others.
anesthesia for bariatric surgery, anesthesia for complicated cardiovascular, anesthesia for major abdominal and vascular surgery, anesthesia for transplant procedures, anesthesia for vascular surgery, clinical research, general and vascular anesthesiology, outcomes research, preoperative assessment.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/2/2016, Dr. Gottlieb has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.